September 28, 2016 5:15 PM ET

Pharmaceuticals

Company Overview of Galleon Pharmaceuticals, Inc.

Company Overview

Galleon Pharmaceuticals, Inc. discovers and develops potential drugs for the treatment of breathing-control conditions associated with surgical anesthesia, drug-induced respiratory depression, pain management, and sleep apnea. It focuses on respiratory depression in the acute care market and sleep apnea in the chronic care market; and ventilator weaning, anesthetic/analgesic-induced respiratory depression, COPD, obesity-hypoventilation syndrome, and other diseases. The company was incorporated in 2003 and is based in Horsham, Pennsylvania.

213 Witmer Road

Horsham, PA 19044

United States

Founded in 2003

Phone:

267-803-1970

Fax:

267-803-1971

Key Executives for Galleon Pharmaceuticals, Inc.

Chief Executive Officer and Director
Age: 48
Managing Partner of Morgenthaler Ventures
Age: 78
Senior Vice President of Drug Discovery
Chief Medical Officer and Senior Vice President of Clinical Research and Development
Compensation as of Fiscal Year 2016.

Galleon Pharmaceuticals, Inc. Key Developments

Galleon Pharmaceuticals Names Joseph Oliveto as Chief Executive Officer

Galleon Pharmaceuticals announced that it has named Joseph Oliveto as Chief Executive Officer, effective immediately. Mr. Oliveto replaces James C. Mannion, Ph.D., who will retire as CEO and continue to serve as a strategic advisor to the company. Mr. Oliveto brings more than 25 years of pharmaceutical and biotech experience across the areas of drug development, commercialization, manufacturing and business development. Most recently, Mr. Oliveto served as President and CEO of Chelsea Therapeutics, a publicly held biopharmaceutical company. During his tenure as CEO, he led the company through the FDA’s approval of Northera™ for the treatment of neurogenic orthostatic hypotension, and the subsequent sale of Chelsea to Lundbeck, Inc.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Galleon Pharmaceuticals, Inc., please visit www.galleonpharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.